Monoamine oxidase and cigarette smoking

被引：163

作者：

Fowler, JS ^{[1
]}

Logan, J ^{[1
]}

Wang, GJ ^{[1
]}

Volkow, ND ^{[1
]}

机构：

[1] Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA

来源：

NEUROTOXICOLOGY | 2003年 / 24卷 / 01期

基金：

美国国家卫生研究院;

关键词：

monoamine oxidase; tobacco; cigarette smoking; positron emission tomography; smoking epidemiology; smoking cessation;

D O I：

10.1016/S0161-813X(02)00109-2

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Current cigarette smokers have reduced monoamine oxidase (MAO) and there is evidence that this is a pharmacological effect of tobacco smoke exposure rather than a biological characteristic of smokers. This article summarizes human and animal studies documenting the inhibitory effects of tobacco smoke on MAO and discusses MAO inhibition in the context of smoking epidemiology, MAO inhibitor compounds in tobacco, reinvestigations of low platelet MAO in psychiatric disorders and smoking cessation. (C) 2002 Elsevier Science Inc. All rights reserved.

引用

收藏

页码：75 / 82

页数：8

相关论文

共 74 条

[1] Platelet monoamine oxidase activity in subgroups of alcoholics and controls: Results from the collaborative study on the genetics of alcoholism [J].

Anthenelli, RM ;

Tipp, J ;

Li, TK ;

Magnes, L ;

Schuckit, MA ;

Rice, J ;

Daw, W ;

Nurnberger, JI .

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1998, 22 (03) :598-604

[2] CDNA CLONING OF HUMAN-LIVER MONOAMINE OXIDASE-A AND OXIDASE-B - MOLECULAR-BASIS OF DIFFERENCES IN ENZYMATIC-PROPERTIES [J].

BACH, AWJ ;

LAN, NC ;

JOHNSON, DL ;

ABELL, CW ;

BEMBENEK, ME ;

KWAN, SW ;

SEEBURG, PH ;

SHIH, JC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4934-4938

[3] MEASUREMENT OF HUMAN CEREBRAL MONOAMINE-OXIDASE TYPE-B (MAO-B) ACTIVITY WITH POSITRON EMISSION TOMOGRAPHY (PET) - A DOSE RANGING STUDY WITH THE REVERSIBLE INHIBITOR RO-19-6327 [J].

BENCH, CJ ;

PRICE, GW ;

LAMMERTSMA, AA ;

CREMER, JC ;

LUTHRA, SK ;

TURTON, D ;

DOLAN, RJ ;

KETTLER, R ;

DINGEMANSE, J ;

DAPRADA, M ;

BIZIERE, K ;

MCCLELLAND, GR ;

JAMIESON, VL ;

WOOD, ND ;

FRACKOWIAK, RSJ .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 (02) :169-173

[4]

BENOWITZ NL, 1988, NEW ENGL J MED, V319, P1318

[5]

Berlin I, 2001, INT J NEUROPSYCHOPH, V4, P33, DOI 10.1017/S1461145701002188

[6] MONOAMINE-OXIDASE-A AND MONOAMINE-OXIDASE-B ACTIVITIES IN HEAVY SMOKERS [J].

BERLIN, I ;

SAID, S ;

SPREUXVAROQUAUX, O ;

OLIVARES, R ;

LAUNAY, JM ;

PUECH, AJ .

BIOLOGICAL PSYCHIATRY, 1995, 38 (11) :756-761

[7] A REVERSIBLE MONOAMINE-OXIDASE-A INHIBITOR (MOCLOBEMIDE) FACILITATES SMOKING CESSATION AND ABSTINENCE IN HEAVY, DEPENDENT SMOKERS [J].

BERLIN, I ;

SAID, S ;

SPREUXVAROQUAUX, O ;

LAUNAY, JM ;

OLIVARES, R ;

MILLET, V ;

LECRUBIER, Y ;

PUECH, AJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (04) :444-452

[8]

Berlin I, 2000, Nicotine Tob Res, V2, P243

[9] Effects of past history of major depression on smoking characteristics, monoamine oxidase-A and -B activities and withdrawal symptoms in dependent smokers [J].

Berlin, I ;

SpreuxVaroquaux, O ;

Said, S ;

Launay, JM .

DRUG AND ALCOHOL DEPENDENCE, 1997, 45 (1-2) :31-37

[10]

Blaschko H, 1937, J PHYSIOL-LONDON, V90, P1

← 1 2 3 4 5 6 7 8 →